Eroms-DT EDTA Injection
Marketer
Alvista Biosciences Pvt Ltd
Salt Composition
Meropenem (1000mg) + Sulbactam (1000mg)
Overview Eroms-DT EDTA Injection
Combiflox, an injectable combination therapy, targets diverse bacterial infections by inhibiting microbial proliferation. Administration must be under a doctor's direct supervision; adhere strictly to the prescribed dosage schedule. Complete the entire course of treatment, even with symptom improvement. Commonly reported side effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin rashes, and localized injection site reactions (redness, swelling, pain) which typically resolve spontaneously. Persistent or worsening side effects necessitate immediate medical attention. Seek immediate medical assistance for allergic reactions, such as skin rashes, itching, swelling, or respiratory distress. Inform your physician of all current medications, especially if pregnant or breastfeeding, before commencing treatment. Alcohol consumption should be avoided due to potential increased drowsiness. While usually non-impairing, refrain from driving if experiencing somnolence or dizziness.
Uses of Eroms-DT EDTA Injection
Life-threatening bacterial infections
Major Benefits of Eroms-DT EDTA Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Eroms-DT EDTA Injection:
- Nausea
- Vomiting
- Diarrhea
- Headache
- Rash
How to use Eroms-DT EDTA Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Eroms-DT EDTA Injection works:
Eroms-DT EDTA Injection unites Meropenem, a bacterial growth inhibitor, and Sulbactam, a beta-lactamase inhibitor. Meropenem's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Sulbactam counters bacterial enzymes that would otherwise neutralize Meropenem, thereby improving Meropenem's efficacy and overcoming bacterial resistance.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Eroms-DT EDTA Injection concurrently with alcohol. Physician consultation is recommended.
PregnancySAFE IF PRESCRIBED
The use of Eroms-DT EDTA Injection during pregnancy is typically regarded as safe. Preclinical trials in animals revealed minimal or no harmful consequences for the fetus; nonetheless, clinical data from human subjects are scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Eroms-DT EDTA Injection without significant safety concerns. Available human data indicate minimal risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Eroms-DT EDTA Injection on driving ability is undetermined. Refrain from operating a vehicle if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney impairment should receive Eroms-DT EDTA Injection only with close medical supervision. Dosage modification may be necessary. A physician should be consulted.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Eroms-DT EDTA Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Eroms-DT EDTA Injection :
Omit a scheduled Eroms-DT EDTA Injection? Seek medical advice immediately.
Facts to Know About Eroms-DT EDTA Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |



